Myasthenia gravis (MG) is a chronic autoimmune disorder of neuromuscolar transmission.
It is characterized by muscle weakness and fatiguability following repetitive activity,
particularly of the face and extremities. The most common clinical features are dysarthria,
ptosis, diplopia, dysphagia and respiratory distress [
[1]
].Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to European Journal of Obstetrics and Gynecology and Reproductive BiologyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Myasthenia gravis and pregnancy.Eur. J. Obstet. Gynecol. Reprod. Biol. 2000; 89: 201-204
- Course and treatment of myasthenia gravis during pregnancy.Neurology. 1999; 52: 447-452
- Myasthenia gravis in mothers and their newborns.Clin. Obstet. Gynecol. 1991; 34: 82-99
- Myasthenia gravis and preeclampsia.Isr. J. Med. Sci. 1994; 30: 229-233
- Preeclampsia and the patient with myasthenia gravis.Obstet. Gynecol. 1979; 54: 355-358
- Preeclampsia: an excessive maternal inflammatory response to pregnancy.Am. J. Obstet. Gynecol. 1999; 180: 499-506
Article info
Publication history
Accepted:
December 22,
2003
Received in revised form:
October 1,
2003
Received:
April 1,
2003
Identification
Copyright
© 2004 Published by Elsevier Inc.
